At this year’s International Liver Conference, PathAI will be sharing three posters featuring new research and innovative applications of AI-powered digital pathology in NASH. The abstracts detail results from a retrospective analysis of liver biopsies from a Phase 2 trial of resmetirom (in partnership with Madrigal Pharmaceuticals), the ability of continuous fibrosis scoring to predict progression (in partnership with Gilead Sciences), and a novel imaging method for detecting and quantifying fibrosis.
London, United Kingdom
Contact Us | Learn More
Developed in partnership with Gilead Sciences, Inc
Presenter: Janani Iyer, PhD
Session Date and Time: June 25, 2022, 9:00 – 18:00
Poster Session: NAFLD: Experimental and pathophysiology
Abstract #3788
View Abstract
Developed in partnership with Madrigal Pharmaceuticals
Presenter: Janani Iyer, PhD
Session Date and Time: June 25, 2022, 9:00 – 18:00
Poster Session: NAFLD: Experimental and pathophysiology
Abstract #3625
View Abstract
Presenter: Justin Lee, PhD
Session Date and Time: June 25, 2022, 9:00 – 18:00
Poster Session: NAFLD: Experimental and pathophysiology
Abstract #3370
View Abstract